Clinical Relevance of GB Virus C & Hepatitis C Virus in HIV+ Women
Clinical Relevance of GB Virus C & Hepatitis C Virus in HIV+ Women
批准号:
7884585
负责人:
JASON T BLACKARD
金额:
$19.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-02 至 2012-06-30
关键词:
AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressBasic ScienceCD4 Lymphocyte CountClinical ResearchCollaborationsCommunicable DiseasesDataDiagnosisDiseaseDisease ProgressionDrug usageFamilyFlaviviridaeFutureGB virusGB virus CGenderGene MutationGenotypeHCV Liver DiseaseHIVHIV SeropositivityHealthHepatitis C virusHigh PrevalenceHigh Risk WomanIndividualInfectionInjection of therapeutic agentInterferonsKnowledgeLaboratoriesLeadLiteratureLiverLiver diseasesLongitudinal StudiesMeasuresMediatingMorbidity - disease rateOpportunistic InfectionsOutcomeOverdoseParticipantPersonsPopulationPrevalenceProspective StudiesPublicationsRNARNA VirusesReceptor GeneRelative (related person)ReportingResourcesRoleSerologicalSex CharacteristicsSubstance abuse problemTimeTreatment outcomeUniversitiesVascular blood supplyViremiaVirusVirus DiseasesVirus ReplicationWomanWorkabstractingantiretroviral therapyclinically relevantcohortethnic minority populationexperiencehuman diseasein vivoinnovationmalemenmortalitynovel therapeuticspublic health relevanceracial and ethnictreatment strategy
中文摘要
描述(由申请方提供):(GBV-C)是一种单链RNA病毒,是已知与丙型肝炎病毒(HCV)最接近的病毒。迄今为止,GBV-C尚未与任何人类疾病相关。然而,一些研究报告了GBV-C病毒血症对HIV疾病进展的有益影响-降低HIV RNA水平,增加CD 4细胞计数和减缓疾病进展-主要在男性比例高的队列中。然而,GBV-C的患病率在男性和女性之间存在显著差异,并且没有大型前瞻性研究检查GBV-C合并感染对女性艾滋病毒疾病进展的影响。在一项初步研究中,我们发现GBV-C基因型2与较高的CD 4细胞计数相比,基因型1,和GBV-C基因型2是更敏感的干扰素治疗后清除比GBV-C基因型1。因此,我们建议在一个特征明确的HIV/AIDS妇女队列中评估GBV-C合并感染的存在和GBV-C基因型在调节HIV疾病进展中的作用,以提高我们对GBV-C/HIV相互作用的认识。这项工作是重要的和创新的,因为没有大的前瞻性研究的作用,GBV-C的共同感染在调节艾滋病毒疾病已报告在艾滋病毒阳性妇女,因为它解决了潜在的有益的相互作用GBV-C和艾滋病毒,可以在未来开发新的治疗策略。公共卫生相关性:迄今为止,GB病毒C型(GBV-C)尚未与任何人类疾病相关,尽管一些研究报告了GBV-C感染对HIV疾病进展的有益影响。GBV-C的患病率可能因性别而异;然而,GBV-C合并感染对HIV疾病的偶然作用,以及GBV-C基因型的潜在调节作用,尚未在女性中进行纵向评估。这些研究可能最终导致治疗艾滋病毒疾病的新的治疗策略,特别是在难以治疗的人群和/或获得抗逆转录病毒治疗有限的个人中。
英文摘要
DESCRIPTION (provided by applicant): (GBV-C) is a single-stranded RNA virus that is the closest known relative of hepatitis C virus (HCV). GBV-C has not been associated with any human disease to date. However, several studies have reported a beneficial effect of GBV-C viremia on HIV disease progression - reduced HIV RNA levels, increased CD4 cell counts, and slower disease progression - predominantly in cohorts with a high proportion of men. However, the prevalence of GBV-C differs significantly between men and women, and no large prospective studies have examined the effects of GBV-C co-infection on HIV disease progression in women. In a preliminary study, we found that GBV-C genotype 2 was associated with higher CD4 cell counts compared to genotype 1, and that GBV-C genotype 2 was more sensitive to clearance after interferon treatment than GBV-C genotype 1. Therefore, we propose to evaluate the presence of GBV-C co-infection and the role of GBV-C genotype in modulating HIV disease progression in a well-characterized cohort of women with HIV/AIDS to enhance our knowledge of GBV-C/HIV interactions. This work is significant and innovative because no large prospective studies of the role of GBV-C co-infection in modulating HIV disease have been reported in HIV positive women and because its addresses a potentially beneficial interaction between GBV-C and HIV that could be exploited in the future to develop novel therapeutic strategies. PUBLIC HEALTH RELEVANCE: To date, GB virus type C (GBV-C) has not been associated with any human disease, although several studies have reported a beneficial effect of GBV-C infection on HIV disease progression. The prevalence of GBV-C may differ by gender; however, the adventitious role of GBV-C co-infection on HIV disease, as well as the potential modulatory effects of GBV-C genotype, has not yet been evaluated in a longitudinal manner in women. Such studies could ultimately lead to novel therapeutic strategies to treat HIV disease, particularly among difficult-to-treat populations and/or individuals with limited access to antiretroviral therapy.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Role of GB virus C in modulating HIV disease.
GB病毒C在调节HIV疾病中的作用。
DOI:
10.1586/eri.12.37
发表时间:
2012-05
期刊:
Expert review of anti-infective therapy
影响因子:
5.7
作者:
[Schwarze-Zander C, Blackard JT, Rockstroh JK]
通讯作者:
Rockstroh JK
DOI:
10.1002/jmv.22029
发表时间:
2011-04
期刊:
JOURNAL OF MEDICAL VIROLOGY
影响因子:
12.7
作者:
[Neibecker, Markus, Schwarze-Zander, Carolynne, Rockstroh, Juergen K., Spengler, Ulrich, Blackard, Jason T.]
通讯作者:
Blackard, Jason T.
DOI:
10.1002/jmv.24836
发表时间:
2017-11
期刊:
Journal of medical virology
影响因子:
12.7
作者:
[Blackard JT, Ma G, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC]
通讯作者:
King CC
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
-
批准号:10542286
-
项目类别:
-
资助金额:$72.17万
-
财政年份:2022
-
负责人:JASON T BLACKARD
-
依托单位:
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
-
批准号:10700069
-
项目类别:
-
资助金额:$69.72万
-
财政年份:2022
-
负责人:JASON T BLACKARD
-
依托单位:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
-
批准号:10203959
-
项目类别:
-
资助金额:$67.47万
-
财政年份:2020
-
负责人:JASON T BLACKARD
-
依托单位:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
-
批准号:10434701
-
项目类别:
-
资助金额:$67.47万
-
财政年份:2020
-
负责人:JASON T BLACKARD
-
依托单位:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
-
批准号:10653831
-
项目类别:
-
资助金额:$67.47万
-
财政年份:2020
-
负责人:JASON T BLACKARD
-
依托单位:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
-
批准号:10029242
-
项目类别:
-
资助金额:$72.0万
-
财政年份:2020
-
负责人:JASON T BLACKARD
-
依托单位:
Omics analysis of HIV during synthetic opioid exposure
-
批准号:10548205
-
项目类别:
-
资助金额:$60.46万
-
财政年份:2019
-
负责人:JASON T BLACKARD
-
依托单位:
Omics analysis of HIV during synthetic opioid exposure
-
批准号:9883771
-
项目类别:
-
资助金额:$60.83万
-
财政年份:2019
-
负责人:JASON T BLACKARD
-
依托单位:
Omics analysis of HIV during synthetic opioid exposure
-
批准号:10158901
-
项目类别:
-
资助金额:$15.02万
-
财政年份:2019
-
负责人:JASON T BLACKARD
-
依托单位:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
-
批准号:9267990
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2013
-
负责人:JASON T BLACKARD
-
依托单位:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
-
批准号:8466568
-
项目类别:
-
资助金额:$30.36万
-
财政年份:2013
-
负责人:JASON T BLACKARD
-
依托单位:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
-
批准号:8658112
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2013
-
负责人:JASON T BLACKARD
-
依托单位:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
-
批准号:8919517
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2013
-
负责人:JASON T BLACKARD
-
依托单位:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
-
批准号:8843272
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2013
-
负责人:JASON T BLACKARD
-
依托单位:
Occult Hepatitis B Infection in South African HIV Patients
-
批准号:8209523
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2011
-
负责人:JASON T BLACKARD
-
依托单位:
Occult Hepatitis B Infection in South African HIV Patients
-
批准号:8265596
-
项目类别:
-
资助金额:$19.02万
-
财政年份:2011
-
负责人:JASON T BLACKARD
-
依托单位:
Clinical Relevance of GB Virus C & Hepatitis C Virus in HIV+ Women
-
批准号:7755157
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2009
-
负责人:JASON T BLACKARD
-
依托单位:
Extrahepatic Replication and Viral Evolution of HCV During HCV/HIV Co-infection
-
批准号:7167475
-
项目类别:
-
资助金额:$17.71万
-
财政年份:2006
-
负责人:JASON T BLACKARD
-
依托单位:
Extrahepatic Replication and Viral Evolution of HCV During HCV/HIV Co-infection
-
批准号:7282702
-
项目类别:
-
资助金额:$17.04万
-
财政年份:2006
-
负责人:JASON T BLACKARD
-
依托单位:
Short-Term Institutional Research Training Grant
-
批准号:10614499
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2002
-
负责人:JASON T BLACKARD
-
依托单位:
海外基金